Trial intelligence / Profile preview

PRP in Carpal Tunnel Syndrome

NCT03184688Completed

Sponsor
Tri-Service General Hospital
Start
Sep 2017
Primary completion
Oct 2019
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Randomised, double-blind trial of platelet-rich plasma in carpal tunnel syndrome (CTS) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Boston Carpal Tunnel Syndrome Questionnaire at 1 year. Started Sep 2017; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT03184688.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03184688.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call